Latest NewsOct 16, 2019

Orgenesis Announces Co-Development Agreement with Accellix

Recent News

Sep 9, 2019
Orgenesis to Present at the 2019 Janney Healthcare Conference
Aug 14, 2019
Orgenesis Reorganizes Its Israel and Korea Subsidiaries to Support Continued Growth
Aug 12, 2019
Orgenesis Second Quarter 2019 Revenue Increases 95% to a Record $7.8 Million
Jun 17, 2019
Orgenesis Granted FDA Orphan Drug Designation for Autologous Insulin Producing Cells in the Treatment of Severe Hypoglycemia-Prone Diabetes Resulting from Total Pancreatectomy
View All Press Releases

Upcoming EventNov 26, 2019 • 10:00am EDT

2019 Annual Meeting of Stockholders
View All Events